- Joined
- 27 December 2010
- Posts
- 1,729
- Reactions
- 48
REC now trading at $6.80.
The further it drops, the more upside is available under the cash offer and the less downside is reflected in the event of a failed deal. However one would expect that a dropping price indicates a reduced expectancy by the market for the deal to succeed - especially as the further IRM.NYS drops due to the unfavourable structure for larger holders.
I've got a small <5000 share parcel in one account and looking to add another in the SMSF. I think the probability looks worthy here.
Something doesn't smell quite right here. But I don't know what it is.
I've only looked superficially at this, so I'd be fairly confident your estimates are far more accurate than mine.
Even taking the IRM shares + 0.50c USD, this seems mis-priced. Surely the regulatory approvals aren't this uncertain.
Looks like the regulators have finally let this one through.That ASIC article in the AFR this week, shows it was a close thing.For small shareholders,like me(A thousand plus REC) it's a no brainer.Take the cash.Eight bucks fifty!Yeah baby and thanks for the divs,too.Just don't forget to pay the CG tax,eh?
Presentation by IRM last night:
Detail on REC at about the 18-22m mark.
Reading the AFR article, you'd think that the takeover is certain to be iced. However, according to IRM (and consistent with their pre-ACCC statements around potential divestments) nothing raised is unexpected and they are working on divestments to gain approval. Still aiming for a Q1 closure.
I guess we will have to wait and see how it unfolds over December...
Still following this deal closely, with the discount trading at elevated levels.
IRM went ex-div last Thursday for what will likely be the last time within the merger window. This may be one of the catalysts for some arbers to come into the market, although the clear catalyst is the approval of ACCC and corresponding bodies for Canada, UK and USA.
I spent some time having a look at the reponses that REC and IRM submitted to the UK authority (found here). To me it sounds like they present a pretty clear case for eventual approval - but obviously there responses will contain bias and a bit of spin.
The chart below tells the story, with some interesting (and large) moves in both IRM and the AUDUSD making the situation far from simple.
Apologies for the unclear axis. White line represents a 5 day moving average of the discount, which I feel gives a better look at how the market is treating the prospect of takeover - given that IRM trades overnight and the AUD can swing around violently in the short term.
From what I've read REC's report was a bit soft.
Yep, still holding my initial retail investment from the beginning. I qualify for the $8.50 cash election so I think it's worth holding to let it play out.Do you have a position (outright or arb'ed)?
I can totally agree with your M&A guy. Despite the two official deferments, it wouldn't surprise me to see it deferred again. Probably looking like mid 2016 based on some of the timelines I saw on the UK stuff alone.One of the M&A analysts I speak to think there's still a LOT of hurdles to clear. Remember how this was supposed to close in Dec15?
Anyways even after it goes unconditional, I reckon it'll still trade nowhere near $8.50. Retail buying will be drowned out by insto/arb selling.
Might be a good time to start opening retail broker accts though!
Australia is very small in the scale of IRM and REC. I think Asia Pacific is something like <5% of the combined entity. So IRM is unlikely to let competition issues get in the way of the much large deal.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?